Department of Health and Human Services
AGENCY:
Assistant Secretary for Planning and Evaluation, HHS.
ACTION:
Notice of meeting.
SUMMARY:
This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council provides advice on ( printed page 792) how to prevent or reduce the burden of Alzheimer's disease and related dementias (ADRD) on people with the disease and their caregivers. During the meeting on January 22, 2024, the Advisory Council will hear updates from the field on implementation of disease-modifying therapies for Alzheimer's disease and outstanding research questions. A panel will present on the latest research on diagnosis and development of treatments for other populations and causes of dementia.
DATES:
The meeting will be January 22, 2024 from 9:30 p.m. to 4:30 p.m. EST.
ADDRESSES:
The meeting will be a hybrid of in-person and virtual. The meeting will be held in Room 800 of the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. It will also stream live at www.hhs.gov/live.
Comments: Time is allocated on the agenda to hear public comments from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited to two (2) minutes per individual. In order to provide a public comment, please register by emailing your name to napa@hhs.gov by Wednesday, January 17. Registered commenters will receive both a dial-in number and a link to join the meeting virtually; individuals will have the choice to either join virtually via the link, or to call in only by using the dial-in number. Note: There may be a 30-45 second delay in the livestream video presentation of the conference. For this reason, if you have pre-registered to submit a public comment, it is important to connect to the meeting by 3:45 p.m. to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. Public commenters will not be admitted to the virtual meeting before 3:30 p.m. but are encouraged to watch the meeting at www.hhs.gov/live. Should you have questions during the session, please email napa@hhs.gov and someone will respond to your message as quickly as possible.
In order to ensure accuracy, please submit a written copy of oral comments for the record by emailing napa@hhs.gov by Tuesday, January 23, 2024. These comments will be shared on the website and reflected in the meeting minutes.
In lieu of oral comments, formal written comments may be submitted for the record by Tuesday, January 23, 2024 to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to napa@hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Helen Lamont, 202-260-6075, helen.lamont@hhs.gov.Note: The meeting will be available to the public live at www.hhs.gov/live.